Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | April 18, 2024 12:31pm

Gainers

  • Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million.
  • Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 53.88% to $6.54. The company's market cap stands at $111.0 million. As per the press release, Q4 earnings came out 3 days ago.
  • 23andMe Holding (NASDAQ:ME) stock moved upwards by 45.48% to $0.52. The company's market cap stands at $250.2 million.
  • SINTX Techs (NASDAQ:SINT) stock moved upwards by 40.75% to $0.05. The company's market cap stands at $6.4 million.
  • iSpecimen (NASDAQ:ISPC) shares moved upwards by 33.19% to $0.28. The company's market cap stands at $2.5 million.
  • Benitec Biopharma (NASDAQ:BNTC) shares moved upwards by 25.62% to $6.03. The market value of their outstanding shares is at $15.6 million.

Losers

  • SeaStar Medical Holding (NASDAQ:ICU) stock decreased by 27.0% to $0.51 during Thursday's regular session. The company's market cap stands at $38.4 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Aptorum Gr (NASDAQ:APM) stock declined by 26.35% to $5.34. The company's market cap stands at $29.2 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock fell 25.12% to $3.13. The market value of their outstanding shares is at $29.9 million.
  • Genetic Technologies (NASDAQ:GENE) stock fell 23.74% to $2.41. The market value of their outstanding shares is at $9.2 million.
  • Ontrak (NASDAQ:OTRK) stock fell 20.39% to $0.29. The market value of their outstanding shares is at $13.8 million. As per the press release, Q4 earnings came out 2 days ago.
  • INVO Bioscience (NASDAQ:INVO) stock decreased by 20.34% to $1.45. The market value of their outstanding shares is at $3.9 million. The company's, Q4 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALRN APM BNTC BPTH GENE ICU INVO ISPC ME NRXP OTRK SINT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist